FORESEE

FORESEE - Novel microsensing platform for remote patient monitoring Chronic heart failure is a relentless condition, affecting millions and straining healthcare resources. With a 5-year mortality rate of 50 % and annual costs exceeding US 30 000 per patient, it is a pressing healthcare dilemma. Patients' lives are burdened by frequent hospitalisations and a high mortality rate. In this context, the EIC-funded FORESEE project will develop implantable microsensing devices. The key to this transformative approach lies in the development of ultra-thin and flexible implantable devices that lack bulky components or batteries. Powered wirelessly, the microsensors promise to revolutionise chronic heart failure monitoring, improving patient care. The focus of FORESEE is to bring this innovative sensing platform from concept to reality. The FORESEE project has received the Transition Open grant from the European Innovation Council (EIC). This is a 2.5 M€ grant, with a duration of 3 years (Grant agreement ID: 101136633). FORESEE is a project developed and managed from the Biomedical Electronics Research Group of Universitat Pompeu Fabra (Barcelona - Spain).

• Employees 2